Quantum-Si: Jeff Keyes

May 02, 2023

Jeff Keyes has been appointed as CFO of proteomics company Quantum-Si, effective May 15. Previously, he held the same position at medical device firm Spinal Elements and at pharmaceuticals developer Custopharm. He also had leadership roles in finance, accounting, and mergers and acquisitions support at various life science companies. Keyes holds a BA in accounting from Western Washington University.

Breaking News

Lucid Diagnostics Raises $22M in Convertible Debt Refinancing
Medicover Genetics Receives IVDR Certification for Genetic Testing Reagent Kit
Final FDA Guidance Lays Path for Drugmakers to Establish Circulating Tumor DNA as Trial Endpoint
Multi-Ancestry Study Uncovers Genetic Contributors to Progressive Eye Disease
GenomeWeb Top 40 Rises 3 Percent in November Amidst Mixed Broader Market

Quantum-Si: Jeff Keyes

Lucid Diagnostics Raises $22M in Convertible Debt Refinancing

Medicover Genetics Receives IVDR Certification for Genetic Testing Reagent Kit

Final FDA Guidance Lays Path for Drugmakers to Establish Circulating Tumor DNA as Trial Endpoint

Multi-Ancestry Study Uncovers Genetic Contributors to Progressive Eye Disease

GenomeWeb Top 40 Rises 3 Percent in November Amidst Mixed Broader Market